Today’s big move higher seems to be driven largely by social media, with retail investors promoting the news that Aptorum recently received a key designation from the U.S. Food and Drug Administration ...
Biopharmaceutical company Aptorum Group Ltd. (NASDAQ:APM) saw its pre-market stock price on Tuesday jump by nearly 300 percent, with investor optimism fueled by the company’s improved earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback